"Das Kantonsspital Frauenfeld stellt die erweiterte Grundversorgung für den westlichen Thurgau sicher. Mit über 1000 motivierten und engagierten Mitarbeitenden setzen wir uns für eine individuelle Behandlung und Betreuung unserer Patientinnen und Patienten ein. Mit 300 Betten und einer modernen, integrierten Infrastruktur decken wir alle Bereiche eines Zentrumsspitals mit den Kliniken für Innere Medizin, Chirurgie, Orthopädie, Gynäkologie & Geburtshilfe, Urologie, Anästhesie & Intensivmedizin ab. Die Zentralen Medizinischen Dienste der Spital Thurgau mit den Instituten für Radiologie, Labormedizin und Pathologie und der Zentralen Sterilgutaufbereitung runden das Angebot ab."

During the past decade, Kantonsspital Frauenfeld conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kantonsspital Frauenfeld" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 8 trials, followed by "Prof. Dr. Volker Viereck" with 3 trials sponsored, "University Hospital, Basel, Switzerland" with 3 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "Cantonal Hospital, Frauenfeld" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Frauenfeld" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Kantonsspital Frauenfeld" with 2 trials as a collaborator, "Swiss National Science Foundation" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Kantonsspital Frauenfeld" are "Prostate Cancer" (2 trials), "Autoimmune" (1 trials), "Benign Prostatic Hyperplasia (BPH)" (1 trials), "Bladder Pain Syndrome" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Kantonsspital Frauenfeld" in a lesser frequency.

Most popular intervention types in "Kantonsspital Frauenfeld" are "Drug" (12 trials), "Device" (6 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (2 trials), "Placebo" (2 trials), "Aspirin" (1 trials), "Atezolizumab" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kantonsspital Frauenfeld" are 11 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kantonsspital Frauenfeld". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kantonsspital Frauenfeld, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kantonsspital Frauenfeld, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".